(Q38968725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

10

Kazuhiko Koike

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Chikako Shibata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Motoko Ohno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Takahiro Kishikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Kaku Goto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Ryosuke Muroyama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Naoya Kato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Takeshi Yoshikawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Akemi Takata

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

English

0 references

publication date

14 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

462-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

42-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25092460%20AND%20SRC:MED&resulttype=core&format=json

Boceprevir for previously treated chronic HCV genotype 1 infection

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

LNA-mediated microRNA silencing in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Telaprevir for previously untreated chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Treatment of HCV infection by targeting microRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Liver-specific microRNA-122: Biogenesis and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Silencing of microRNAs in vivo with 'antagomirs'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Novel therapies for hepatitis C - one pill fits all?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Boceprevir for untreated chronic HCV genotype 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Response-guided telaprevir combination treatment for hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Regioselective reactions for programmable resveratrol oligomer synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Modulation of microRNA processing by p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024

Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.024